SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -96.8% | 51,794 | -93.0% | 0.00% | -100.0% |
| Q2 2023 | $964 | +13.1% | 741,806 | +53.2% | 0.01% | -10.0% |
| Q1 2023 | $852 | -99.8% | 484,151 | +302.4% | 0.01% | +100.0% |
| Q2 2022 | $498,000 | -12.8% | 120,316 | +57.8% | 0.01% | +66.7% |
| Q4 2021 | $571,000 | +65.5% | 76,247 | +98.6% | 0.00% | +50.0% |
| Q3 2021 | $345,000 | -65.6% | 38,393 | -54.2% | 0.00% | -77.8% |
| Q2 2021 | $1,002,000 | +237.4% | 83,755 | +339.5% | 0.01% | +50.0% |
| Q4 2020 | $297,000 | +206.2% | 19,058 | +84.5% | 0.01% | +100.0% |
| Q3 2020 | $97,000 | -47.3% | 10,329 | -49.2% | 0.00% | -66.7% |
| Q3 2019 | $184,000 | +46.0% | 20,351 | +78.5% | 0.01% | -84.7% |
| Q2 2015 | $126,000 | – | 11,400 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |